6QAD-HUZ

IC50 14.0 nM for human BChE Residual activity of 63% for human AChE. Compound 13 of the paper Meden et al. derived from Tryptophan

General

Type : Derivative of Tryptophan,Indole

Chemical_Nomenclature : (2S)-2-(butylamino)-N-[2-[4-(dimethylamino)cyclohexyl]ethyl]-3-(1H-indol-3-yl)propanamide

Canonical SMILES : CCCCNC(CC1=CNC2=CC=CC=C21)C(=O)NCCC3CCC(CC3)N(C)C

InChI : InChI=1S\/C25H40N4O\/c1-4-5-15-26-24(17-20-18-28-23-9-7-6-8-22(20)23)25(30)27-16-14-19-10-12-21(13-11-19)29(2)3\/h6-9,18-19,21,24,26,28H,4-5,10-17H2,1-3H3,(H,27,30)\/t19?,21?,24-\/m0\/s1

InChIKey : NDNXTWYOKPDDNQ-HQOBLLPJSA-N

Other name(s) : HUZ


MW : 412.6

Formula : C25H40N4O

CAS_number :

PubChem : 137552757

UniChem : NDNXTWYOKPDDNQ-HQOBLLPJSA-N

IUPHAR :

Wikipedia :

Target

Families : 6QAD-HUZ ligand of proteins in family: BCHE

Stucture : 6QAD Human Butyrylcholinesterase in complex with ((S)-2-(butylamino)-N-(2-(4-(dimethylamino)cyclohexyl)ethyl)-3-(1H-indol-3-yl)propanamide

Protein : human-BCHE

References (1)

Title : Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease - Meden_2019_Chem.Commun.(Camb)_55_3765
Author(s) : Meden A , Knez D , Jukic M , Brazzolotto X , Grsic M , Pislar A , Zahirovic A , Kos J , Nachon F , Svete J , Gobec S , Groselj U
Ref : Chem Commun (Camb) , 55 :3765 , 2019
Abstract : Meden_2019_Chem.Commun.(Camb)_55_3765
ESTHER : Meden_2019_Chem.Commun.(Camb)_55_3765
PubMedSearch : Meden_2019_Chem.Commun.(Camb)_55_3765
PubMedID: 30864579
Gene_locus related to this paper: human-BCHE